Prenatal ontogeny as a susceptibility period for cortical GABA neuron disturbances in schizophrenia

D W Volk1, D A Lewis2

  • 1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA 15213, United States.

Neuroscience
|June 18, 2013
PubMed

Insights

Schizophrenia

Area of Science:

  • Neuroscience
  • Developmental Neuroscience
  • Psychiatry

Background:

  • Cognitive deficits in schizophrenia are linked to GABA neuron dysfunction in the prefrontal cortex (PFC).
  • These deficits manifest early, even before psychosis onset, suggesting prenatal origins.
  • The ontogeny of cortical GABA neurons may be disrupted by early insults.

Purpose of the Study:

  • To investigate whether schizophrenia pathogenesis involves prenatal disruption of cortical GABA neuron development.
  • To explore the role of gestational insults in altering GABA neuron ontogeny and leading to cognitive deficits.

Main Methods:

  • Review of postmortem human brain tissue studies on prefrontal GABA neuron alterations.
  • Examination of developmental regulators governing GABA neuron birth, migration, specification, maturation, and survival.
  • Analysis of studies showing altered expression of these regulators in schizophrenia's PFC.

Main Results:

  • Evidence suggests prenatal insults initiate a pathogenic process affecting GABA neuron ontogeny.
  • Alterations in specific GABA neuron subpopulations in the PFC point to a prenatal origin.
  • Disturbances in developmental regulators and maternal-fetal environment (e.g., immune activation) are implicated.

Conclusions:

  • Schizophrenia may stem from prenatal disruptions in cortical GABA neuron development.
  • Understanding altered GABA neuron ontogeny is crucial for schizophrenia pathogenesis research.
  • Future research should focus on critical questions regarding prenatal influences on GABA neuron development.

Related Concept Videos

Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...